MASCC Headlines

MASCC Headlines

Events  |  Society News  |  MASCC Media

2019 Annual Cancer Treatment-Related Adverse Events Symposium

Matti Aapro Awarded MASCC’s 2016 Distinguished Service Award

Matti Aapro, MD, was selected as the recipient of MASCC’s 2016 Distinguished Service Award. The Award recognizes meritorious achievement and outstanding contributions to the Society and its mission. Candidates are nominated by their peers in recognition of exemplary leadership and accomplishments in support of the Society’s mission. Currently Dean of the Multidisciplinary Oncology Institute, Genolier, Switzerland, Matti Aapro is widely recognized for his achievements in numerous areas of oncology and supportive cancer care. His expertise and energetic leadership have significantly furthered the aims of MASCC around the world.

Deborah Walker Honored by AACN

MASCC member Deborah K. Walker, DNP, was awarded a 2015 Award in Excellence and Innovation in Teaching from the American Association of Colleges of Nursing for a project-based learning activity designed to increase nursing students’ awareness of cancer patients’ psychosocial needs  a project that helps bridge the gap between theory and practice. Deborah was subsequently awarded funding to lead a project team in the development of a Cancer Resource application. The application is now being used in Alabama (US) and Deborah hopes to expand its use in many other communities.

Cancer Resources App

The Cancer Resources App, developed by a project team led by MASCC member Deborah K. Walker, identifies local and national resources for cancer patients and caregivers, provides a summary of resources with contact information and maps, and includes an option to email selected resources. It is available form the App Store, Google Play, and  
For more information, contact Deborah Walker at [email protected].

New Antiemetic Guidelines

The MASCC/ESMO Antiemetic Guidelines have been updated as of March, 2016. The guidelines are based on the Copenhagen Consensus Conference on Antiemetic Therapy, June 2015, and have been endorsed by both MASCC and ESMO. This set of evidence-based guidelines represents several important changes and first-time inclusions.

FDA Approves Single-Dose Fosaprepitant

In February, 2016, the US Food and Drug Administration approved a single-use injection of fosaprepitant dimeglumine (Emend®) to prevent delayed nausea and vomiting in adults receiving an initial or repeat course of moderately emetogenic chemotherapy.

AgeCare - Improving the Care of Older Cancer Patients
AgeCare®, an Elite Research Center based in the Department of Oncology, Odense University Hospital, Odense, Denmark, is directed by Jørn Herrstedt, MD, DMSc. The center aims to optimize cancer therapy and supportive care for older cancer patients through a wide range of research projects.
<< first < Prev 21 22 23 24 25 26 Next > last >>

Page 21 of 26